Lewes, DE -- (SBWIRE) -- 10/11/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Cirrus Logic, Inc. (NASDAQ:CRUS), Lam Research Corporation (NASDAQ:LRCX), CONN'S, Inc. (NASDAQ:CONN), Cubist Pharmaceuticals Inc (NASDAQ:CBST).
Cirrus Logic, Inc. (NASDAQ:CRUS), increased3.29% and closed at $23.55 on a traded volume of 1.86 million shares, in comparison to 3.17 million shares of average trading volume. So far this year, the stock is down over -18.71%.
The company has a total market capitalization of $1.49Billion and its total outstanding shares are 63.45 million.
Will CRUS Continue To Move Higher? Find Out Here
Cirrus Logic, Inc., a fabless semiconductor company, develops analog and mixed-signal integrated circuits (ICs) for a range of consumer and industrial markets.
Lam Research Corporation (NASDAQ:LRCX), soared4.26% and closed at $52.72 on a traded volume of 1.85 million shares, whereas its average trading volume is 1.69 million shares. In the last three months, the stock is up6.47%. The Intra-day range for the stock is $51.26 and $52.87.
Will LRCX Continue To Move Higher? Find Out Here
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits.
CONN'S, Inc. (NASDAQ:CONN), jumped up8.81 % and closed at $58.40. So far in three months, the stock is up 5.95%. The 52-week range for the stock is $22.81 and $69.32 and during the previous trading session it marked$58.43 as its highest price. The stock initially exchanged hands with a price of $55.10 and the overall traded volume that day was 1.85 million shares.
Will CONN Continue To Move Higher? Find Out Here
Conn’s, Inc. is engaged in the specialty retail of durable consumer products in the United States.
Cubist Pharmaceuticals Inc (NASDAQ:CBST) after opening its shares at the price of $65.02, jumped up2.91% to close the day at $65.50. The stock ended on a traded volume of 1.84 million shares, in comparison to 1.47million shares of average trading volume. The 52-week range for the stock is $38.53 and $68.00 and during the previous trading session the stock scored the highest price of $66.37. It started the day at $65.02.
Why Should Investors Buy CBST After The Recent Gain? Just Go Here and Find Out.
Cubist Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of pharmaceutical products for various medical needs in the acute care environment in the United States.
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)